Recruiting

Non-invasive Brain Stimulation

Sponsor:

Laval University

Code:

NCT02776319

Conditions

Tobacco Use Disorder

Eligibility Criteria

Sex: All

Age: 21 - 60

Healthy Volunteers: Not accepted

Interventions

Non-invasive brain stimulation (active)

Non-invasive brain stimulation (sham)

Study Details

Brief summary:

The objective of the study is to determine the effect of non-invasive brain stimulation on craving for tobacco and brain metabolites.

Conditions

Tobacco Use Disorder

Study ID

NCT02776319

Start date

May, 2016

Status verified date

May, 2016

Completion date

Dec, 2016

Anticipated

Primary completion date

Sep, 2016

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 60

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Tobacco use disorder (DSM-V)

Exclusion Criteria:

  • Other psychiatric disorders
  • Contraindication to non-invasive brain stimulation and MRI

Study Design

Enrollment

15 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: Active

Non-invasive brain stimulation (active)

placebo comparator: Sham/Placebo

Non-invasive brain stimulation (sham)

Interventions

Non-invasive brain stimulation (active)

Non-invasive brain stimulation (active)

Non-invasive brain stimulation (sham)

Non-invasive brain stimulation (sham)

Primary outcome measure

  • Tobacco craving [ Time Frame: During experimentation ]

Central Contacts and Locations

Central contacts

Antoine Hone-Blanchet, MSC

4185299141antoine.hone-blanchet.1@ulaval.ca

Shirley Fecteau, PHD

4185299141Shirley.Fecteau@fmed.ulaval.ca

Locations

Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Social

Recruiting

Quebec City, Quebec, Canada, G1M2S8

More Information

Sponsor

Laval University

Last update posted

May 18, 2016

Last verified

May, 2016

Keywords

  • Non-invasive brain stimulation
  • tobacco use disorder
  • craving

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Laval University on 2016-05-18.